Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aeilko H Zwinderman

Showing results (391-400 of 480) with videos related to

Pageof 48
Sort By:
Vaccine|February 21, 2023
Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS studySophie L Campman, Gwen van Rossem, Anders Boyd, et al.
Journal of the American Heart Association|March 31, 2021
Dutch Outcome in Implantable Cardioverter-Defibrillator Therapy: Implantable Cardioverter-Defibrillator-Related Complications in a Contemporary Primary Prevention CohortMarit van Barreveld, Tom E Verstraelen, Pascal F H M van Dessel, et al.
Heart Rhythm|January 19, 2021
Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD)Jim T Vehmeijer, Zeliha Koyak, Jan M Leerink, et al.
European Journal of Heart Failure|October 30, 2018
Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHFToru Suzuki, Yoshiyuki Yazaki, Adriaan A Voors, et al.
Journal of the American College of Cardiology|February 2, 2018
Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHFWouter Ouwerkerk, Aeilko H Zwinderman, Leong L Ng, et al.
Annals of the Rheumatic Diseases|May 11, 2007
Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatmentMarion A J van Rossum, Renée M van Soesbergen, Maarten Boers, et al.
International Journal of Cardiology|November 29, 2018
Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fractionKoen W Streng, Jan F Nauta, Hans L Hillege, et al.
Ophthalmology. Retina|May 5, 2020
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized TrialMaartje J C Vader, Ann-Sofie M E Schauwvlieghe, Frank D Verbraak, et al.
Plos One|January 12, 2018
Effect of a lifestyle intervention in obese infertile women on cardiometabolic health and quality of life: A randomized controlled trialLotte van Dammen, Vincent Wekker, Anne M van Oers, et al.
Arthritis and Rheumatism|February 7, 2003
Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment methodMarion A J van Rossum, Aeilko H Zwinderman, Maarten Boers, et al.
Pageof 48

Showing results (391-400 of 480) with videos related to

Sort By:
Pageof 48
Vaccine|February 21, 2023
Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS studySophie L Campman, Gwen van Rossem, Anders Boyd, et al.
Journal of the American Heart Association|March 31, 2021
Dutch Outcome in Implantable Cardioverter-Defibrillator Therapy: Implantable Cardioverter-Defibrillator-Related Complications in a Contemporary Primary Prevention CohortMarit van Barreveld, Tom E Verstraelen, Pascal F H M van Dessel, et al.
Heart Rhythm|January 19, 2021
Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD)Jim T Vehmeijer, Zeliha Koyak, Jan M Leerink, et al.
European Journal of Heart Failure|October 30, 2018
Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHFToru Suzuki, Yoshiyuki Yazaki, Adriaan A Voors, et al.
Journal of the American College of Cardiology|February 2, 2018
Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHFWouter Ouwerkerk, Aeilko H Zwinderman, Leong L Ng, et al.
Annals of the Rheumatic Diseases|May 11, 2007
Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatmentMarion A J van Rossum, Renée M van Soesbergen, Maarten Boers, et al.
International Journal of Cardiology|November 29, 2018
Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fractionKoen W Streng, Jan F Nauta, Hans L Hillege, et al.
Ophthalmology. Retina|May 5, 2020
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized TrialMaartje J C Vader, Ann-Sofie M E Schauwvlieghe, Frank D Verbraak, et al.
Plos One|January 12, 2018
Effect of a lifestyle intervention in obese infertile women on cardiometabolic health and quality of life: A randomized controlled trialLotte van Dammen, Vincent Wekker, Anne M van Oers, et al.
Arthritis and Rheumatism|February 7, 2003
Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment methodMarion A J van Rossum, Aeilko H Zwinderman, Maarten Boers, et al.
Pageof 48